Heat Biologics, Inc. is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. It is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.
Sold my position at $1.27 for profits. Got in again with the identical long position at $1.22 and now will hold through the earnings.
Leonx 1.27 ? was well over that today .... (maybe you mean you made 1.27 x share ) if so bravo ..nice one
@Ciao I bought some shares at $0.94 and sold them at $1.27. And on last Friday, I bought some again at $1.22 and currently holding them now.
I thought you meant today... as I scalped them did see that price... still well done today hod 1.90 .. I admire how you all can see all that green and not taken them I must be the poor relative good luck
@Ciao thanks! I am only holding a very small position thus it may not hurt too much if it goes south. Will hold through the earnings (11-Aug-16) and see what it can bring.
Grabbed some for my IRA. It is running like a mofo. I want to lock in some profits but I am changing brokerages and so my account is locked smh. Long term target is around $3.30:
